ICD10 code of Goldenhar Syndrome and ICD9 code

Goldenhar syndrome, also known as oculo-auriculo-vertebral (OAV) spectrum, is primarily classified under ICD-10 code Q87.0 (Congenital malformation syndromes predominantly affecting facial appearance). While ICD-9 coding has been largely superseded, it was historically categorized under 759.89 (Other specified congenital anomalies).

What exactly is Goldenhar syndrome?

Goldenhar syndrome is a rare congenital condition characterized by the incomplete development of the ear, nose, soft palate, lip, and mandible on one or both sides of the body. Because it exists on a spectrum, the presentation of Goldenhar syndrome varies significantly from person to person. Our community at DiseaseMaps.org currently supports 173 individuals living with the complexities of this diagnosis, highlighting the diverse range of clinical manifestations, which often involve ocular dermoids, vertebral anomalies, and hearing loss.

How is Goldenhar syndrome classified and coded?

In clinical practice, accurate coding is essential for insurance reimbursement and tracking patient populations. Goldenhar syndrome is typically identified by the following codes:

• ICD-10-CM: Q87.0 (Congenital malformation syndromes predominantly affecting facial appearance).


• ICD-9-CM: 759.89 (Other specified congenital anomalies).


• Orphanet code: ORPHA:374 (Oculo-auriculo-vertebral spectrum).

It is important to note that because Goldenhar syndrome affects multiple systems, clinicians may also use supplemental codes to specify individual manifestations, such as conductive hearing loss or specific vertebral scoliosis, to ensure comprehensive care documentation.

Is Goldenhar syndrome considered a hereditary condition?

Most cases of Goldenhar syndrome occur sporadically, meaning they happen by chance in families with no prior history of the condition. While the exact cause remains elusive, medical researchers believe it likely results from a combination of genetic factors and environmental influences during early embryonic development. In rare instances, familial cases have been reported, suggesting a potential autosomal dominant or recessive inheritance pattern, but this is not the clinical norm for the majority of patients diagnosed with Goldenhar syndrome.

What are the common clinical features to monitor?

Management of Goldenhar syndrome requires a multidisciplinary approach due to the systemic nature of the condition. Patients often require a team including craniofacial surgeons, otolaryngologists, ophthalmologists, and geneticists. Common features requiring ongoing medical oversight include:

• Craniofacial: Microtia (small or absent external ear) or hemifacial microsomia.


• Ocular: Epibulbar dermoids or colobomas of the upper eyelid.


• Skeletal: Hemivertebrae, scoliosis, or fusion of cervical vertebrae.


• Cardiac/Renal: Structural heart defects or kidney anomalies, which occur in a subset of the patient population.

Next steps

• Consult with a clinical geneticist to discuss potential underlying causes and family planning.


• Coordinate care through a dedicated craniofacial center that specializes in managing the complexities of Goldenhar syndrome.


• Connect with the 173 members in our DiseaseMaps.org community to share experiences and coping strategies.


• Keep a detailed binder of all medical records, including imaging and surgical history, using the ICD-10 Q87.0 code for consistency.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• National Institutes of Health (NIH) - Genetic and Rare Diseases Information Center (GARD): Oculo-auriculo-vertebral spectrum.


• Orphanet: Oculo-auriculo-vertebral spectrum (ORPHA:374).


• OMIM (Online Mendelian Inheritance in Man): Oculo-auriculo-vertebral spectrum (Entry #164210).


• DiseaseMaps.org: Patient community data and support resources for rare diseases.